GlassScriptPhysician profile
Liesel Ernst
NPI 1417226382
$2,795.63
in general payments reported to CMS, 2019-2025
18 companies · $869 in 2025
The $869 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.40 · 2022: $105 · 2023: $961 · 2024: $849 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Consulting Fee: $375 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.72 |
| Consulting Fee | $375.00 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $743.57 | 2023-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $394.25 | 2022-2024 | |
| Leo Pharma INC. | $375.00 | 2025 | Adbry |
| Lilly USA, LLC | $257.50 | 2021-2025 | Ebglyss, Taltz, Zepbound |
| Incyte Corporation | $195.30 | 2022-2024 | Opzelura, Iclusig |
| Regeneron Healthcare Solutions, INC. | $177.41 | 2023-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $170.97 | 2023-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $147.59 | 2023 | |
| Ucb, INC. | $67.55 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $46.79 | 2023-2024 | |
| Pfizer INC. | $43.13 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $38.38 | 2022-2024 | |
| Genzyme Corporation | $32.52 | 2024 | |
| Biofrontera INC. | $27.83 | 2024 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Biowound Solutions, INC. | $22.83 | 2025 | Bio-Connekt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $21.63 | 2023 | Vtama |
| Almirall LLC | $19.78 | 2023 | Klisyri |
| Janssen Scientific Affairs, LLC | $13.60 | 2023 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liesel Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.